ONCOZ.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$6M	+93.3%	$-0.83	$-0.83–$-0.83	—	1
2027	$14M	+148.3%	$0.00	$0.00–$0.00	—	0
2028	$20M	+41.0%	$0.00	$0.00–$0.00	—	0

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

DCF fair valuemodel estimate

Intrinsic value

$0.85

Price

$3.11

Implied downside

-73%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
ONCOZ.STOncoZenge AB (publ)	$3.19	-0.93%	$45M	—
ACOU.STAcouSort AB	$2.66	-1.12%	$56M	—
ATORX.STAlligator Bioscience AB (publ)	$0.02	+4.19%	$1M	—
EXPRS2.STExpreS2ion Biotech Holding AB (publ)	$1.32	+6.00%	$3M	—
LPGO.STLipigon Pharmaceuticals AB (publ)	$0.00

OncoZenge AB (publ)

OncoZenge AB (publ) operates as a pharmaceutical company with a focus on developing medical solutions that offer supportive care for cancer patients. A significant product in its pipeline is BupiZenge, which has successfully completed Phase 2 clinical trials for the management of oral mucositis. This company was established in 2020 and conducts its operations from its headquarters in Bromma, Sweden. Notably, OncoZenge AB (publ) is a subsidiary entity of Moberg Pharma AB (publ).

www.oncozenge.se

Employees: 1
IPO / List date: Feb 12, 2021
HQ: SE

Held by traders on TradeandTell

No one on the platform currently holds ONCOZ.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in ONCOZ.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded ONCOZ.ST yet.